113 related articles for article (PubMed ID: 32668313)
1. IPM712, a vanillin derivative as potential antitumor agents, displays better antitumor activity in colorectal cancers cell lines.
Ma W; Zhang Q; Li X; Ma Y; Liu Y; Hu S; Zhou Z; Zhang R; Du K; Syed A; Yao X; Chen P
Eur J Pharm Sci; 2020 Sep; 152():105464. PubMed ID: 32668313
[TBL] [Abstract][Full Text] [Related]
2. A vanillin derivative suppresses the growth of HT29 cells through the Wnt/β-catenin signaling pathway.
Ma W; Li X; Song P; Zhang Q; Wu Z; Wang J; Li X; Xu R; Zhao W; Liu Y; Liu H; Yao X; Tang X; Chen P
Eur J Pharmacol; 2019 Apr; 849():43-49. PubMed ID: 30707959
[TBL] [Abstract][Full Text] [Related]
3. Vanillin Derivatives Reverse
Zhou Z; Wang Y; Ji R; Zhang D; Ma C; Ma W; Ma Y; Jiang X; Du K; Zhang R; Chen P
Front Pharmacol; 2022; 13():841918. PubMed ID: 35308221
[TBL] [Abstract][Full Text] [Related]
4. Vanillin downregulates NNMT and attenuates NNMT‑related resistance to 5‑fluorouracil via ROS‑induced cell apoptosis in colorectal cancer cells.
Li G; Kong B; Tong Q; Li Y; Chen L; Zeng J; Yu H; Xie X; Zhang J
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907844
[TBL] [Abstract][Full Text] [Related]
5. Resistance to 3-HTMC-Induced Apoptosis Through Activation of PI3K/Akt, MEK/ERK, and p38/COX-2/PGE
Semaan J; Pinon A; Rioux B; Hassan L; Limami Y; Pouget C; Fagnère C; Sol V; Diab-Assaf M; Simon A; Liagre B
J Cell Biochem; 2016 Dec; 117(12):2875-2885. PubMed ID: 27192488
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
7. PTEN Overexpression Cooperates With Lithium to Reduce the Malignancy and to Increase Cell Death by Apoptosis via PI3K/Akt Suppression in Colorectal Cancer Cells.
de Araujo WM; Robbs BK; Bastos LG; de Souza WF; Vidal FC; Viola JP; Morgado-Diaz JA
J Cell Biochem; 2016 Feb; 117(2):458-69. PubMed ID: 26224641
[TBL] [Abstract][Full Text] [Related]
8. PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence.
Narayanankutty A
Curr Drug Targets; 2019; 20(12):1217-1226. PubMed ID: 31215384
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of kaempferol and 5‑fluorouracil on the growth of colorectal cancer cells by regulating the PI3K/Akt signaling pathway.
Li Q; Wei L; Lin S; Chen Y; Lin J; Peng J
Mol Med Rep; 2019 Jul; 20(1):728-734. PubMed ID: 31180555
[TBL] [Abstract][Full Text] [Related]
11. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells.
Yao W; Lin Z; Shi P; Chen B; Wang G; Huang J; Sui Y; Liu Q; Li S; Lin X; Liu Q; Yao H
Biochem Pharmacol; 2020 Jan; 171():113680. PubMed ID: 31669234
[TBL] [Abstract][Full Text] [Related]
12. Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1.
Alqurashi N; Hashimi SM; Alowaidi F; Ivanovski S; Wei MQ
Oncol Rep; 2018 Aug; 40(2):1083-1092. PubMed ID: 29845289
[TBL] [Abstract][Full Text] [Related]
13. 4'-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling.
Sun D; Zhang F; Qian J; Shen W; Fan H; Tan J; Li L; Xu C; Yang Y; Cheng H
Chem Biol Interact; 2018 Dec; 296():26-33. PubMed ID: 30217479
[TBL] [Abstract][Full Text] [Related]
14. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
15. AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway.
Ghanaatgar-Kasbi S; Amerizadeh F; Rahmani F; Hassanian SM; Khazaei M; Ferns GA; Avan A
IUBMB Life; 2019 Dec; 71(12):1929-1936. PubMed ID: 31359579
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer evaluations of novel 1H-imidazole [4,5-f][1,10] phenanthroline derivative for the treatment of colorectal cancer.
Hu S; Ma W; Wang J; Ma Y; Zhou Z; Zhang R; Du K; Zhang H; Sun M; Jiang X; Tu H; Tang X; Yao X; Chen P
Eur J Pharmacol; 2022 Aug; 928():175120. PubMed ID: 35753402
[TBL] [Abstract][Full Text] [Related]
17. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
18. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
Hu F; He Z; Sun C; Rong D
Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
[TBL] [Abstract][Full Text] [Related]
20. Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
Lin J; Feng J; Yang H; Yan Z; Li Q; Wei L; Lai Z; Jin Y; Peng J
Oncol Rep; 2017 Oct; 38(4):2293-2300. PubMed ID: 28849113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
